Appili Therapeutics Inc. (TSX:APLI)
Canada · Delayed Price · Currency is CAD 0.0150
0.00 (0.00%)
Apr 10, 2026, 10:46 AM EST
Appili Therapeutics Employees
Appili Therapeutics had 7 employees as of March 31, 2025. The number of employees did not change compared to the previous year.
Employees
7
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
29.47K CAD
Profits / Employee
-423.37K CAD
Market Cap
1.99M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Mar 31, 2025 | 7 | 0 | - | 7 | 0 |
| Mar 31, 2024 | 7 | -2 | -22.22% | 7 | 0 |
| Mar 31, 2023 | 9 | 1 | 12.50% | 8 | 1 |
| Mar 31, 2022 | 8 | -8 | -50.00% | 8 | 0 |
| Mar 31, 2021 | 16 | - | - | 14 | 2 |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Appili Therapeutics News
- 14 days ago - Appili Therapeutics to Exhibit at World Vaccine Congress Washington - GlobeNewsWire
- 7 weeks ago - Appili Therapeutics Announces Closing of Second Tranche of Non-Brokered Private Placement - GlobeNewsWire
- 2 months ago - Appili Therapeutics Reports Financial and Operational Results for Third Quarter of Fiscal Year 2026 - GlobeNewsWire
- 5 months ago - Appili Therapeutics Reports Financial and Operational Results for Second Quarter of Fiscal Year 2026 - GlobeNewsWire
- 6 months ago - Appili Therapeutics to Attend BARDA Innovation Symposium 2025 - GlobeNewsWire
- 6 months ago - Appili Therapeutics and its Partner Vitalex Biosciences Awarded Contract from NIAID Valued at up to US$40 Million to Develop Fungal Vaccine VXV-01 - GlobeNewsWire
- 7 months ago - Appili Therapeutics Announces Results of Annual and Special Meeting of Shareholders - GlobeNewsWire
- 7 months ago - Appili Therapeutics to Present Progress on Tularemia Biodefense Vaccine at NATO CBRN Conference - GlobeNewsWire